Houlihan Lokey Inc.

With the Fed expected to lower interest rates this year, conditions are ripe for more deals, though uncertainties over international relations and U.S. politics may temper enthusiasm.

"We've had high interest rates before. Dealflow doesn't stop," says one mid-market banker.

The deal will allow Pharmavite to continue to grow in the women’s health market, which has been a top priority with products including Uqora and Equelle supplements.